|
H2AFZ expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.032900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.51779999999691E-05 |
| Normal-vs-Stage2 |
3.640100E-02 |
| Normal-vs-Stage3 |
1.107230E-01 |
| Normal-vs-Stage4 |
6.20209999999677E-05 |
| Stage1-vs-Stage2 |
1.656840E-01 |
| Stage1-vs-Stage3 |
1.853700E-02 |
| Stage1-vs-Stage4 |
9.582100E-02 |
| Stage2-vs-Stage3 |
5.542600E-01 |
| Stage2-vs-Stage4 |
1.738390E-02 |
| Stage3-vs-Stage4 |
3.696700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.018400E-04 |
| Normal-vs-AfricanAmerican |
8.629400E-04 |
| Normal-vs-Asian |
3.040400E-01 |
| Caucasian-vs-AfricanAmerican |
3.769400E-01 |
| Caucasian-vs-Asian |
6.591600E-01 |
| AfricanAmerican-vs-Asian |
7.953800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.631300E-04 |
| Normal-vs-Female |
6.411800E-04 |
| Male-vs-Female |
7.892200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.301100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.135570E-03 |
| Normal-vs-Age(61-80Yrs) |
6.757700E-04 |
| Normal-vs-Age(81-100Yrs) |
6.354000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.788770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.023400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.561200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.274000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.342400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.625600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.062480E-02 |
| Normal-vs-Grade 2 |
2.2627999999969E-05 |
| Normal-vs-Grade 3 |
2.088500E-02 |
| Normal-vs-Grade 4 |
6.007500E-04 |
| Grade 1-vs-Grade 2 |
4.540000E-01 |
| Grade 1-vs-Grade 3 |
1.663810E-01 |
| Grade 1-vs-Grade 4 |
8.756000E-01 |
| Grade 2-vs-Grade 3 |
2.728300E-02 |
| Grade 2-vs-Grade 4 |
2.384400E-01 |
| Grade 3-vs-Grade 4 |
2.928100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.884090E-03 |
| Normal-vs-ccB subtype |
8.218700E-04 |
| ccA subtype-vs-ccB subtype |
2.366800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.717260E-03 |
| Normal-vs-N1 |
7.298500E-03 |
| N0-vs-N1 |
5.152100E-02 |
|
|
